Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Complement Dependent and Independent Interaction Between Bovine Conglutinin and Mycobacterium bovis BCG: Implications in Bovine Tuberculosis.

Mehmood A, Kouser L, Kaur A, Holmskov U, Al-Ahdal MN, Sim RB, Kishore U, Tsolaki AG.

Front Immunol. 2019 Feb 5;9:3159. doi: 10.3389/fimmu.2018.03159. eCollection 2018.

2.

Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5.

Al-Mozaini MA, Tsolaki AG, Abdul-Aziz M, Abozaid SM, Al-Ahdal MN, Pathan AA, Murugaiah V, Makarov EM, Kaur A, Sim RB, Kishore U, Kouser L.

Front Immunol. 2018 May 8;9:533. doi: 10.3389/fimmu.2018.00533. eCollection 2018.

3.

Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR.

Pednekar L, Pathan AA, Paudyal B, Tsolaki AG, Kaur A, Abozaid SM, Kouser L, Khan HA, Peerschke EI, Shamji MH, Stenbeck G, Ghebrehiwet B, Kishore U.

Front Immunol. 2016 Dec 13;7:567. doi: 10.3389/fimmu.2016.00567. eCollection 2016.

4.

Pulmonary surfactant protein SP-D opsonises carbon nanotubes and augments their phagocytosis and subsequent pro-inflammatory immune response.

Pondman KM, Paudyal B, Sim RB, Kaur A, Kouser L, Tsolaki AG, Jones LA, Salvador-Morales C, Khan HA, Ten Haken B, Stenbeck G, Kishore U.

Nanoscale. 2017 Jan 19;9(3):1097-1109. doi: 10.1039/c6nr08807d.

5.

Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T Cells.

Pondman KM, Tsolaki AG, Paudyal B, Shamji MH, Switzer A, Pathan AA, Abozaid SM, Ten Haken B, Stenbeck G, Sim RB, Kishore U.

J Biomed Nanotechnol. 2016 Jan;12(1):197-216.

PMID:
27301184
6.

Complement factor H interferes with Mycobacterium bovis BCG entry into macrophages and modulates the pro-inflammatory cytokine response.

Abdul-Aziz M, Tsolaki AG, Kouser L, Carroll MV, Al-Ahdal MN, Sim RB, Kishore U.

Immunobiology. 2016 Sep;221(9):944-52. doi: 10.1016/j.imbio.2016.05.011. Epub 2016 May 24.

7.

A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway.

Kouser L, Abdul-Aziz M, Tsolaki AG, Singhal D, Schwaeble WJ, Urban BC, Khan HA, Sim RB, Kishore U.

Mol Immunol. 2016 May;73:76-87. doi: 10.1016/j.molimm.2016.03.005. Epub 2016 Apr 6.

8.

Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes.

Pondman KM, Pednekar L, Paudyal B, Tsolaki AG, Kouser L, Khan HA, Shamji MH, Ten Haken B, Stenbeck G, Sim RB, Kishore U.

Nanomedicine. 2015 Nov;11(8):2109-18. doi: 10.1016/j.nano.2015.06.009. Epub 2015 Jul 11.

9.

Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.

Deacon RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, Nachtigall FM, Santos LS, Tsolaki AG, Pednekar L, Kishore U, Biekofsky RR, Vasquez RA, Cogram P.

Curr Alzheimer Res. 2015;12(4):314-22.

PMID:
25817252
10.

Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages.

Pondman KM, Sobik M, Nayak A, Tsolaki AG, Jäkel A, Flahaut E, Hampel S, Ten Haken B, Sim RB, Kishore U.

Nanomedicine. 2014 Aug;10(6):1287-99. doi: 10.1016/j.nano.2014.02.010. Epub 2014 Mar 6.

11.

Purification of surfactant protein D (SP-D) from pooled amniotic fluid and bronchoalveolar lavage.

Dodagatta-Marri E, Qaseem AS, Karbani N, Tsolaki AG, Waters P, Madan T, Kishore U.

Methods Mol Biol. 2014;1100:273-90. doi: 10.1007/978-1-62703-724-2_22.

PMID:
24218267
12.

Purification of native surfactant protein SP-A from pooled amniotic fluid and bronchoalveolar lavage.

Karbani N, Dodagatta-Marri E, Qaseem AS, Madhukaran P, Waters P, Tsolaki AG, Madan T, Kishore U.

Methods Mol Biol. 2014;1100:257-72. doi: 10.1007/978-1-62703-724-2_21.

PMID:
24218266
13.

Mycobacterium tuberculosis antigen 85B and ESAT-6 expressed as a recombinant fusion protein in Mycobacterium smegmatis elicits cell-mediated immune response in a murine vaccination model.

Tsolaki AG, Nagy J, Leiva S, Kishore U, Rosenkrands I, Robertson BD.

Mol Immunol. 2013 Jul;54(3-4):278-83. doi: 10.1016/j.molimm.2012.11.014. Epub 2013 Jan 16.

PMID:
23333882
14.

An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.

Nayak A, Dodagatta-Marri E, Tsolaki AG, Kishore U.

Front Immunol. 2012 Jun 7;3:131. doi: 10.3389/fimmu.2012.00131. eCollection 2012.

15.

Mycobacterium tuberculosis: immune evasion, latency and reactivation.

Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S.

Immunobiology. 2012 Mar;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008. Epub 2011 Jul 18. Review.

PMID:
21813205
16.

The non-classical functions of the classical complement pathway recognition subcomponent C1q.

Nayak A, Ferluga J, Tsolaki AG, Kishore U.

Immunol Lett. 2010 Jul 8;131(2):139-50. doi: 10.1016/j.imlet.2010.03.012. Epub 2010 Apr 8. Review.

PMID:
20381531
17.

Innate immune recognition in tuberculosis infection.

Tsolaki AG.

Adv Exp Med Biol. 2009;653:185-97. Review.

PMID:
19799120
18.

Genomic interrogation of ancestral Mycobacterium tuberculosis from south India.

Narayanan S, Gagneux S, Hari L, Tsolaki AG, Rajasekhar S, Narayanan PR, Small PM, Holmes S, Deriemer K.

Infect Genet Evol. 2008 Jul;8(4):474-83. Epub 2007 Sep 29.

19.

Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis.

Chen J, Tsolaki AG, Shen X, Jiang X, Mei J, Gao Q.

Tuberculosis (Edinb). 2007 Sep;87(5):446-9. Epub 2007 Jul 13.

PMID:
17632035
20.

Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis.

Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN, Van Soolingen D, Small PM.

J Clin Microbiol. 2005 Jul;43(7):3185-91.

21.

High-throughput method for detecting genomic-deletion polymorphisms.

Goguet de la Salmonière YO, Kim CC, Tsolaki AG, Pym AS, Siegrist MS, Small PM.

J Clin Microbiol. 2004 Jul;42(7):2913-8.

22.

Stable association between strains of Mycobacterium tuberculosis and their human host populations.

Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4871-6. Epub 2004 Mar 23.

23.

Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains.

Tsolaki AG, Hirsh AE, DeRiemer K, Enciso JA, Wong MZ, Hannan M, Goguet de la Salmoniere YO, Aman K, Kato-Maeda M, Small PM.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4865-70. Epub 2004 Mar 15.

24.

The in vitro evolution of BCG vaccines.

Mostowy S, Tsolaki AG, Small PM, Behr MA.

Vaccine. 2003 Oct 1;21(27-30):4270-4.

PMID:
14505909
25.

High rates of recombination in otitis media isolates of non-typeable Haemophilus influenzae.

Cody AJ, Field D, Feil EJ, Stringer S, Deadman ME, Tsolaki AG, Gratz B, Bouchet V, Goldstein R, Hood DW, Moxon ER.

Infect Genet Evol. 2003 May;3(1):57-66.

26.
27.
28.

Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping.

Helweg-Larsen J, Tsolaki AG, Miller RF, Lundgren B, Wakefield AE.

QJM. 1998 Dec;91(12):813-20.

PMID:
10024946
29.
30.

Supplemental Content

Loading ...
Support Center